Investment Summary

Advantage Capital Partners Invests In Nanopoint

On November 3, 2005, growth capital firm Advantage Capital Partners invested in medical products company Nanopoint

Investment Highlights
  • This is Advantage Capital Partners’ 4th transaction in the Medical Products sector.
  • This is Advantage Capital Partners’ 37th transaction in the United States.
  • This is Advantage Capital Partners’ 2nd transaction in Hawaii.
Investment Fate
  • Nanopoint was sold to a strategic buyer in 2011.

Investment Summary

Date 2005-11-03
Target Nanopoint
Sector Medical Products
Investor(s) Advantage Capital Partners
Deal Type Venture

Target

Nanopoint

Honolulu, Hawaii, United States
Nanopoint develops and markets unique cellular imaging systems for the life sciences market. Nanopoint's cellTRAY®-based solutions are miniaturized cell culture and imaging systems for live cell-based assays. Nanopoint was founded in 2002 and is based in Honolulu, Hawaii.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Advantage Capital Partners

New Orleans, Louisiana, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1992
PE ASSETS 2.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.


DEAL STATS #
Overall 37 of 329
Sector: Medical Products M&A 4 of 14
Type: Venture M&A Deals 25 of 125
State: Hawaii M&A 2 of 4
Country: United States M&A 37 of 325
Year: 2005 M&A 10 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-10-24 Kereos

St. Louis, Missouri, United States

Kereos develops targeted therapeutics and molecular imaging agents that detect and attack cancer and cardiovascular disease earlier and more specifically than previously possible.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-11-15 NetRegulus

Needham, Massachusetts, United States

NetRegulus, Inc. provides web-based Enterprise Regulatory Management software that enables life science companies to effectively manage clinical study and quality data.

Buy $6M